Relative Strength Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.87 USD | +0.17% |
|
-2.43% | +8.67% |
| 07-20 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | +0.17% | -2.43% | +8.67% | +29.45% | +28.06% | 5.74B |  |  |  |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
